Two years after AstraZeneca splashed out $1 billion upfront for rights to Daiichi Sankyo's TROP2-targeting antibody-drug conjugate DS-1062, the drug has generate promising results in advanced ...
Throughline is a time machine. Each episode, we travel beyond the headlines to answer the question, "How did we get here?" We use sound and stories to bring history to life and put you into the middle ...
November 18, 2025 • President Trump says he won’t “rule out” sending troops to Venezuela, and over the weekend, the world’s largest aircraft carrier arrived in the Caribbean Sea. We discuss why the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback